BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31880771)

  • 1. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
    Piper C; Zhou V; Komorowski R; Szabo A; Vincent B; Serody J; Alegre ML; Edelson BT; Taneja R; Drobyski WR
    Blood; 2020 Feb; 135(8):568-581. PubMed ID: 31880771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.
    Gartlan KH; Koyama M; Lineburg KE; Chang K; Ensbey KS; Kuns RD; Henden AS; Samson LD; Clouston AD; Lopez AF; MacDonald KPA; Hill GR
    Blood Adv; 2019 Oct; 3(19):2859-2865. PubMed ID: 31585949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.
    Piper C; Hainstock E; Yin-Yuan C; Chen Y; Khatun A; Kasmani MY; Evans J; Miller JA; Gorski J; Cui W; Drobyski WR
    Blood Adv; 2022 May; 6(9):2791-2804. PubMed ID: 35015822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new role for an old cytokine: GM-CSF amplifies GVHD.
    Waller EK
    Blood; 2020 Feb; 135(8):520-521. PubMed ID: 32078687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
    Lin CC; Bradstreet TR; Schwarzkopf EA; Sim J; Carrero JA; Chou C; Cook LE; Egawa T; Taneja R; Murphy TL; Russell JH; Edelson BT
    Nat Commun; 2014 Apr; 5():3551. PubMed ID: 24699451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
    Koyama M; Hill GR
    Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.
    Zhou V; Agle K; Chen X; Beres A; Komorowski R; Belle L; Taylor C; Zhu F; Haribhai D; Williams CB; Verbsky J; Blumenschein W; Sadekova S; Bowman E; Ballantyne C; Weaver C; Serody DA; Vincent B; Serody J; Cua DJ; Drobyski WR
    J Clin Invest; 2016 Sep; 126(9):3541-55. PubMed ID: 27500496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.
    Ullrich E; Abendroth B; Rothamer J; Huber C; Büttner-Herold M; Buchele V; Vogler T; Longerich T; Zundler S; Völkl S; Beilhack A; Rose-John S; Wirtz S; Weber GF; Ghimire S; Kreutz M; Holler E; Mackensen A; Neurath MF; Hildner K
    J Clin Invest; 2018 Mar; 128(3):916-930. PubMed ID: 29376889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state memory-phenotype conventional CD4
    Cho MJ; Lee HG; Yoon JW; Kim GR; Koo JH; Taneja R; Edelson BT; Lee YJ; Choi JM
    Exp Mol Med; 2023 May; 55(5):1033-1045. PubMed ID: 37121980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells.
    Tugues S; Amorim A; Spath S; Martin-Blondel G; Schreiner B; De Feo D; Lutz M; Guscetti F; Apostolova P; Haftmann C; Hasselblatt P; Núñez NG; Hottiger MO; van den Broek M; Manz MG; Zeiser R; Becher B
    Sci Transl Med; 2018 Nov; 10(469):. PubMed ID: 30487251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease.
    Engel JA; Lee HJ; Williams CG; Kuns R; Olver S; Lansink LI; Soon MS; Andersen SB; Powell JE; Svensson V; Teichmann SA; Hill GR; Varelias A; Koyama M; Haque A
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BHLHE40 Regulates Myeloid Cell Polarization through IL-10-Dependent and -Independent Mechanisms.
    Hendrix SV; Mreyoud Y; McNehlan ME; Smirnov A; Chavez SM; Hie B; Chamberland MM; Bradstreet TR; Webber AM; Kreamalmeyer D; Taneja R; Bryson BD; Edelson BT; Stallings CL
    J Immunol; 2024 Jun; 212(11):1766-1781. PubMed ID: 38683120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
    Yu XZ; Albert MH; Anasetti C
    J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells.
    Gerritsen WR; O'Reilly RJ
    Blood; 1994 Sep; 84(6):1906-12. PubMed ID: 7521693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4
    Chung J; Radojcic V; Perkey E; Parnell TJ; Niknafs Y; Jin X; Friedman A; Labrecque N; Blazar BR; Brennan TV; Siebel CW; Maillard I
    J Immunol; 2019 Jul; 203(2):557-568. PubMed ID: 31182480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
    Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
    Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BHLHE40 drives protective polyfunctional CD4 T cell differentiation in the female reproductive tract against Chlamydia.
    Mercado MAB; Li Q; Quick CM; Kim Y; Palmer R; Huang L; Li LX
    PLoS Pathog; 2024 Jan; 20(1):e1011983. PubMed ID: 38271477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
    Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BHLHE40 Promotes T
    Jarjour NN; Bradstreet TR; Schwarzkopf EA; Cook ME; Lai CW; Huang SC; Taneja R; Stappenbeck TS; Van Dyken SJ; Urban JF; Edelson BT
    J Immunol; 2020 Feb; 204(4):923-932. PubMed ID: 31900338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of LTB4/BLT1 axis facilitates generation of mouse GM-CSF-induced long-lasting antitumor immunologic memory by enhancing innate and adaptive immune systems.
    Yokota Y; Inoue H; Matsumura Y; Nabeta H; Narusawa M; Watanabe A; Sakamoto C; Hijikata Y; Iga-Murahashi M; Takayama K; Sasaki F; Nakanishi Y; Yokomizo T; Tani K
    Blood; 2012 Oct; 120(17):3444-54. PubMed ID: 22936657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.